Hideyuki Mototani

723 citations
9 papers · 571 indexed · h-index 9
Topics
Peptidase Inhibition and Analysis (3 papers)Protease and Inhibitor Mechanisms (3 papers)Signaling Pathways in Disease (2 papers)
Partner nations
JapanUnited StatesChina

In The Last Decade

Hideyuki Mototani

9 papers receiving 561 citations

Peers

Hideyuki Mototani
Comparison fields: 5 of 81
  • Molecular Biology 293
  • Oncology 155
  • Rheumatology 110
  • Nutrition and Dietetics 106
  • Cancer Research 88
Replace Kathleen M. Gillooly with:
Kathleen M. Gillooly United States
Giang T. Le Australia
Greg J. Pankhurst Australia
David P. Kosow United States
Takashi Tsuruo Japan
Xiaolu Zhang China
Chiu-Mei Sung United States
Laura L. Rokosz United States
Piriya Wongkongkathep United States
Hideyuki Mototani relative to Kathleen M. Gillooly United States Kathleen M. Gillooly's profile →
Citations per field
00.5×5.9×
Kathleen M. Gillooly · 1×
Citations per year

Countries citing papers authored by Hideyuki Mototani

Since Specialization
Citations

This map shows the geographic impact of Hideyuki Mototani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Mototani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Mototani more than expected).

Fields of papers citing papers by Hideyuki Mototani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyuki Mototani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Mototani. The network helps show where Hideyuki Mototani may publish in the future.

Co-authorship network of co-authors of Hideyuki Mototani

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyuki Mototani. A scholar is included among the top collaborators of Hideyuki Mototani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyuki Mototani. Hideyuki Mototani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 59
2 19
3 42
4 37
5 49
6 14
7 35
8 86
9 230

About Hideyuki Mototani

Hideyuki Mototani is a scholar working on Cancer Research, Oncology and Rheumatology, having authored 9 papers that have together received 571 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Signaling Pathways in Disease (2 papers). The work is most often cited by research in Rheumatology (110 citations), Neurology (60 citations) and Nutrition and Dietetics (106 citations). Hideyuki Mototani has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Hideo Takeuchi, Takashi Miura, Aritoshi Iida, Shiro Ikegawa, Takashi Santou, Hideyuki Oki, Kenjiro Sato, Osamu Uchikawa, Haruhiko Kuno and Yoshio Yamamoto. Their work appears in journals such as Biochemistry, Journal of Medicinal Chemistry and Human Molecular Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026